Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Choroidal Neovascularization
100%
Multimodal Imaging
100%
Ophthalmology
100%
Aflibercept
66%
Sensitivity and Specificity
56%
Autofluorescence
54%
Spectral Domain Optical Coherence Tomography
54%
Optical Coherence Tomography
50%
Angiography
50%
Visual Field Test
50%
Maculopathy
50%
Clinical Trial
50%
Diabetic Retinopathy
50%
Image Quality
50%
Stargardt Disease
50%
Gene Therapy
50%
Sex Differences
50%
Antiviral Therapy
50%
Acute Retinal Necrosis
50%
Phototoxicity
37%
Retinal Pigment Epithelium
37%
Equine Infectious Anemia Virus
37%
Adverse Event
37%
Monotherapy
37%
Dystrophy
33%
Fundus Photography
29%
Vision
29%
Ocular Hypertension
25%
Subretinal Drug Administration
25%
Best Corrected Visual Acuity
25%
Retina Image
25%
Drug Megadose
25%
Antivirus Agent
25%
Program Director
20%
Disease
18%
Fundus Fluorescein Angiography
16%
Visual Acuity
16%
Medicine
16%
Bevacizumab
16%
Echography
16%
Odds Ratio
16%
Thymus Cancer
16%
Retina Injury
12%
Outer Nuclear Layer
12%
Visual Impairment
12%
Surgical Technique
12%
Tissue Injury
12%
Agents Acting on the Eye
12%
Function Test
12%
Enucleation
12%
Keyphrases
Myopic Choroidal Neovascularization (mCNV)
87%
Arc Welding
50%
Photic Maculopathy
50%
OCT Angiography
50%
Multimodal Imaging
50%
Injection Force
50%
Choroidal Folds
50%
Occlusive Vasculopathy
50%
Good's Syndrome
50%
Pictor
40%
Select Committees
33%
Sight-threatening Diabetic Retinopathy
30%
Welder's Maculopathy
25%
En Face OCT
25%
Grader
25%
Pattern Dystrophy
25%
Macular Flecks
25%
Total Electric Field
25%
Gradability
20%
Fluorescein Angiography
17%
Injection Speed
16%
Peak Density
15%
Interval Method
15%
Medical Retina
14%
Nave
12%
Structural OCT
12%
Spectral Domain Optical Coherence Tomography (SD-OCT)
12%
Left Eye
12%
Right Eye
12%
Central Vision
12%
Macular
12%
Fundus Autofluorescence
12%
Bevacizumab Treatment
12%
Visual Acuity
12%
Stargardt Dystrophy
12%
Color Fundus Photography
12%
Aflibercept
12%
Reduced Sample Size
12%
B Cell Immunodeficiency
12%
Necrotizing Retinitis
12%
Anterior Segment Neovascularization
12%
Immunocompromised Conditions
12%
Chest Computed Tomography
12%
CD4+ Count
12%
Density Method
10%
Sampling Window
10%
Inter-session
10%
Background Diabetic Retinopathy
10%
Image Focusing
10%
Intravitreal Aflibercept
8%
Nursing and Health Professions
Aflibercept
100%
Sensitivity and Specificity
50%
Subretinal Neovascularization
50%
Optical Coherence Tomography
50%
Visual Impairment
50%
Syringe
50%
Angiography
50%
Central Macular Thickness
27%
Endothelial Cell Growth Factor
8%
Age Related Macular Degeneration
6%
Ranibizumab
5%
Tuberculin
5%
Glaucoma
5%
